Screener
Ionis Pharmaceuticals IONS Income Tax Reconciliation Foreign Income Tax Rate Differential
Income Tax Reconciliation Foreign Income Tax Rate Differential at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential.
The source filing: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:25 PM EST
- Fiscal year
- FY2026
- Accession
- 0000874015-26-000115
| Pre-tax loss | $(379,601) | ||
| Statutory rate | (79,716) | 21.0% | % |
| State and local income tax, net of federal income tax effect (a) | 353 | (0.1 | )% |
| Foreign tax effects | (118) | 0.0% | % |
| Effect of cross-border tax laws | 459 | (0.1 | )% |
| Changes in unrecognized tax benefits | 12,145 | (3.2 | )% |
| Changes in valuation allowances | 93,773 | (24.7 | )% |
| Tax credits: |
Item 15. Exhibits and Financial Statement Schedules
FAQ
- What is Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential?
- Ionis Pharmaceuticals (IONS) reported income tax reconciliation foreign income tax rate differential of -$29.5K in Q4 2025.
- How has Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential changed year-over-year?
- Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential decreased by 886.7% year-over-year, from $3.75K to -$29.5K.
- What is the long-term trend for Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential has grown at a 131.6% compound annual growth rate (CAGR), from -$22K to -$118K.
- What does income tax reconciliation foreign income tax rate differential mean?
- This represents the net tax impact resulting from the difference between the U.S. federal statutory tax rate and the tax rates applicable in foreign jurisdictions where the company conducts business. It highlights the tax benefit or cost associated with international operations. This is critical for evaluating the tax efficiency of the company's global corporate structure.
Ask your AI about Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude